The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma
Open accessAbstract
Little is known about epigenetic silencing of genes by promoter hypermethylation in lobular breast cancers. The promoter methylation status of 5 cancer‐related genes (RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist) was evaluated in 2 types of lobular cancers, in situ (LCIS) and invasive lobular carcinomas (ILC) (n = 32), and compared to ductal in situ (DCIS) and invasive (IDC) breast cancers (n = 71). By using methylation‐specific PCR (MSP), 100% of ILC and 69% of LCIS cases were found to have 1 or more hypermethylated genes among the panel of 5 genes (compared to 100% IDC and 95% of DCIS). Two or more hypermethylated genes were detected per tumor in 79% of invasive and 61% of in situ lobular carcinomas compared to 81% of IDC and 77% of DCIS. By contrast, DNA from nearly all normal reduction mammoplasty tissues (n = 8) was unmethylated for the 5 genes. The methylation profiles of lobular vs. ductal carcinomas with respect to RASSF1A, Cyclin D2, RARβ, and Hin‐1 genes were similar, suggesting that gene silencing by promoter hypermethylation is likely to be important in both groups of diseases. Distinctly different, Twist was hyper‐ methylated less often in ILC (16%, 3/19 cases) than in IDC (56%, 15/27 cases) (p = 0.01). These results suggest that these 2 types of tumors share many common methylation patterns and some molecular differences. Additional studies might lend further understanding into the etiology and clinical behavior of this tumor type. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Diagnostic Histopathology of the Breast
Page, D. L., & Anderson, T. J. (1988) · Medical Entomology and Zoology · Cited by 1,064
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
Trends in Incidence Rates of Invasive Lobular and Ductal Breast Carcinoma
Li, C. I., Anderson, B. O., Daling, J. R., & Moe, R. E. (2003) · JAMA · doi:10.1001/jama.289.11.1421 · Cited by 577
twist is a potential oncogene that inhibits apoptosis
Maestro, R., Tos, A. P. D., Hamamori, Y., Krasnokutsky, S., Sartorelli, V., Kedes, L., Doglioni, C., Beach, D. H., & Hannon, G. J. (1999) · Genes & Development · doi:10.1101/gad.13.17.2207 · Cited by 516
Grases, P. J. (2002) · Progresos de Obstetricia y Ginecología · doi:10.1016/s0304-5013(02)75784-1 · Cited by 498
Compromised HOXA5 function can limit p53 expression in human breast tumours
Raman, V., Martensen, S. A., Reisman, D., Evron, E., Odenwald, W. F., Jaffee, E., Marks, J., & Sukumar, S. (2000) · Nature · doi:10.1038/35016125 · Cited by 482
Self-citationDNA methylation and breast carcinogenesis
Widschwendter, M., & Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205606 · Cited by 457
High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100566997 · Cited by 444
Self-citationDNA methylation, chromatin inheritance, and cancer
Rountree, M. R., Bachman, K. E., Herman, J. G., & Baylin, S. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204339 · Cited by 384
Agathanggelou, A., Honorio, S., Macartney, D. P., Martinez, A., Dallol, A., Rader, J., Fullwood, P., Chauhan, A., Walker, R., Shaw, J. A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204175 · Cited by 376
Hamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P. L., Wu, H.-Y., Wang, J. Y. J., Nakatani, Y., & Kedes, L. (1999) · Cell · doi:10.1016/s0092-8674(00)80553-x · Cited by 368
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
Evron, E., Dooley, W. C., Umbricht, C. B., Rosenthal, D., Sacchi, N., Gabrielson, E., Soito, A. B., Hung, D. T., Ljung, B.-M., Davidson, N. E., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04501-3 · Cited by 333
Self-citationDNA Methylation: An Alternative Pathway to Cancer
Wajed, S. A., Laird, P. W., & DeMeester, T. R. (2001) · Annals of Surgery · doi:10.1097/00000658-200107000-00003 · Cited by 327
Graff, J. R., Herman, J. G., Myöhänen, S., Baylin, S. B., & Vertino, P. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22322 · Cited by 319
Dreijerink, K., Braga, E., Kuzmin, I., Geil, L., Duh, F.-M., Angeloni, D., Zbar, B., Lerman, M. I., Stanbridge, E. J., Minna, J. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131216298 · Cited by 294
Nass, S. J., Herman, J. G., Gabrielson, E. W., Iversen, P. W., Parl, F. F., Davidson, N. E., & Graff, J. R. (2000) · PubMed · Cited by 292
Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A. T., Marks, J., & Sukumar, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204438 · Cited by 291
Self-citationDammann, R., Yang, G., & Pfeifer, G. P. (2001) · PubMed · Cited by 280
Acs, G., Lawton, T. J., Rebbeck, T. R., LiVolsi, V. A., & Zhang, P. J. (2001) · American Journal of Clinical Pathology · doi:10.1309/fdhx-l92r-batq-2ge0 · Cited by 280
A SAGE (serial analysis of gene expression) view of breast tumor progression.
PORTER, D. A., Krop, I. E., Nasser, S. M., Sgroi, D. C., Kaelin, C. M., Marks, J. R., Riggins, G. J., & Polyák, K. (2001) · PubMed · Cited by 238
Nacht, M., Ferguson, A. T., Zhang, W., Petroziello, J. M., Cook, B. P., Gao, Y. H., Maguire, S., Riley, D., Coppola, G., Landes, G. M., et al. (1999) · PubMed · Cited by 237
Self-citationMultiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
Droufakou, S., Deshmane, V., Roylance, R., Hanby, A., Tomlinson, I., & Hart, I. R. (2001) · International Journal of Cancer · doi:10.1002/ijc.1208 · Cited by 229
Yang, X., Ferguson, A. T., Nass, S. J., Phillips, D. L., Butash, K. A., Wang, S. M., Herman, J. G., & Davidson, N. E. (2000) · PubMed · Cited by 228
Quantitative Assessment of Promoter Hypermethylation during Breast Cancer Development
Lehmann, U., Länger, F., Feist, H., Glöckner, S., Hasemeier, B., & Kreipe, H. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64880-8 · Cited by 222
Evron, E., Umbricht, C. B., Korz, D., Raman, V., Loeb, D. M., Niranjan, B., Buluwela, L., Weitzman, S. A., Marks, J. R., & Sukumar, S. V. (2001) · PubMed · Cited by 213
Self-citationOrtiz-Vega, S., Khokhlatchev, A., Nedwidek, M., Zhang, X.-F., Dammann, R., Pfeifer, G. P., & Avruch, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205192 · Cited by 209
Sirchia, S. M., Ferguson, A. T., Sironi, E., Subramanyan, S., Orlandi, R., Sukumar, S., & Sacchi, N. (2000) · Oncogene · doi:10.1038/sj.onc.1203456 · Cited by 195
Self-citationTWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage
Lee, M.-S., Lowe, G. N., Strong, D. D., Wergedal, J. E., & Glackin, C. A. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19991215)75:4<566::aid-jcb3>3.0.co;2-0 · Cited by 194
Seewaldt, V. L., Johnson, B. S., Parker, M. B., Collins, S., & Swisshelm, K. L. (1995) · PubMed · Cited by 192
The Loss of Estrogen and Progesterone Receptor Gene Expression in Human Breast Cancer
Lapidus, R. G., Nass, S. J., & Davidson, N. E. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018778403001 · Cited by 192
Changing incidence rate of invasive lobular breast carcinoma among older women
Li, C. I., Anderson, B. O., Porter, P., Holt, S. K., Daling, J. R., & Moe, R. E. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2561::aid-cncr19>3.0.co;2-x · Cited by 162
Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
Fujii, H., Biel, M. A., Zhou, W., Weitzman, S. A., Baylin, S. B., & Gabrielson, E. W. (1998) · Oncogene · doi:10.1038/sj.onc.1201976 · Cited by 154
Byun, D.-S., Lee, M., Chae, K. S., Ryu, B. G., & Chi, S. G. (2001) · PubMed · Cited by 138
Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee, M., Kim, H. Y., Byun, D.-S., Lee, S., Lee, C. H., Kim, J. I., Chang, S., & Chi, S. G. (2001) · PubMed · Cited by 134
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells
Krop, I. E., Sgroi, D. C., PORTER, D. A., Lunetta, K. L., LeVangie, R., Seth, P., Kaelin, C. M., Rhei, E., Bosenberg, M., Schnitt, S. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171138398 · Cited by 130
Bovenzi, V., & Momparler, R. L. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100294 · Cited by 118
Epigenetic Regulation of Gelsolin Expression in Human Breast Cancer Cells
Mielnicki, L. M., Ying, A., Head, K. L., Asch, H. L., & Asch, B. B. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4461 · Cited by 104
Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland
Verkooijen, H. M., Fioretta, G., Vlastos, G., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11032 · Cited by 94
Retinoid receptors in human lung cancer and breast cancer
Zhang, X.-K., Liu, Y., & Lee, M. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00102-6 · Cited by 77
Bovenzi, V., Lê, N. L. O., Côté, S., et al. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199906000-00007 · Cited by 74
Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells
Sweeney, K. J. E., Šarčević, B., Sutherland, R. L., & Musgrove, E. A. (1997) · Oncogene · doi:10.1038/sj.onc.1200951 · Cited by 54
Raffo, P., Emionite, L., Colucci, L., Belmondo, F., Mg, M., Bollag, W. B., & Toma, S. (2000) · PubMed · Cited by 48
Genes, Chromatin, and Breast Cancer: An Epigenetic Tale
Mielnicki, L. M., Asch, H. L., & Asch, B. B. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011356623442 · Cited by 44
Cited by
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., & Helin, K. (2006) · Genes & Development · doi:10.1101/gad.381706 · Cited by 1,257
Martin, T. A., Goyal, A., Watkins, G., & Jiang, W. G. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.04.010 · Cited by 486
Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer
Lehmann, U., Hasemeier, B., Christgen, M., Müller, M., Römermann, D., Länger, F., & Kreipe, H. (2008) · The Journal of Pathology · doi:10.1002/path.2251 · Cited by 460
Molecular and Cellular Heterogeneity in Breast Cancer
Rivenbark, A. G., O’Connor, S. M., & Coleman, W. B. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.08.002 · Cited by 327
Metadata
- Authors
- Fackler, M. J., McVeigh, M., Evron, E., Garrett, E., Mehrotra, J., Polyak, K., Sukumar, S., & Argani, P.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2003-09-18
- Volume
- 107
- Issue
- 6
- Pages
- 970-975
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2054974538
- Cited by
- 253
- References
- 45
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.